CORSINI, MICHELA
 Distribuzione geografica
Continente #
NA - Nord America 3.946
EU - Europa 2.541
AS - Asia 2.270
SA - Sud America 360
AF - Africa 63
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.203
Nazione #
US - Stati Uniti d'America 3.864
SG - Singapore 785
PL - Polonia 711
CN - Cina 660
IT - Italia 550
BR - Brasile 303
DE - Germania 281
UA - Ucraina 247
HK - Hong Kong 231
VN - Vietnam 190
FI - Finlandia 170
GB - Regno Unito 140
FR - Francia 94
TR - Turchia 75
IN - India 74
RU - Federazione Russa 72
IE - Irlanda 55
NL - Olanda 47
ES - Italia 42
CA - Canada 36
ID - Indonesia 34
JP - Giappone 34
BD - Bangladesh 33
SE - Svezia 25
AR - Argentina 24
ZA - Sudafrica 24
MX - Messico 23
BE - Belgio 21
IQ - Iraq 21
PK - Pakistan 18
AU - Australia 17
CZ - Repubblica Ceca 15
IR - Iran 15
AT - Austria 14
KR - Corea 12
PH - Filippine 11
CH - Svizzera 10
NO - Norvegia 10
TH - Thailandia 9
CO - Colombia 8
EG - Egitto 8
KG - Kirghizistan 8
LT - Lituania 8
MA - Marocco 8
ET - Etiopia 7
GR - Grecia 6
IL - Israele 6
MY - Malesia 6
SA - Arabia Saudita 6
AZ - Azerbaigian 5
EC - Ecuador 5
JM - Giamaica 5
KZ - Kazakistan 5
PE - Perù 5
SK - Slovacchia (Repubblica Slovacca) 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
DK - Danimarca 4
LK - Sri Lanka 4
NG - Nigeria 4
RO - Romania 4
CR - Costa Rica 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
HN - Honduras 3
MU - Mauritius 3
PA - Panama 3
PY - Paraguay 3
UY - Uruguay 3
UZ - Uzbekistan 3
AL - Albania 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CU - Cuba 2
EU - Europa 2
GE - Georgia 2
GT - Guatemala 2
JO - Giordania 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
NP - Nepal 2
NZ - Nuova Zelanda 2
SN - Senegal 2
TW - Taiwan 2
BH - Bahrain 1
BN - Brunei Darussalam 1
FJ - Figi 1
GD - Grenada 1
HR - Croazia 1
LV - Lettonia 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
OM - Oman 1
PS - Palestinian Territory 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
Totale 9.199
Città #
Warsaw 706
Ashburn 483
Singapore 441
Fairfield 314
Brescia 227
Hong Kong 219
San Jose 211
Woodbridge 182
Jacksonville 180
Chandler 177
Ann Arbor 170
Houston 150
Beijing 140
Seattle 112
Los Angeles 111
The Dalles 109
New York 106
Cambridge 105
Helsinki 100
Princeton 100
Wilmington 96
Council Bluffs 85
Dearborn 71
Milan 68
Munich 68
Dallas 62
Dublin 55
Istanbul 54
Lauterbourg 53
Ho Chi Minh City 50
Nanjing 50
Dong Ket 41
San Francisco 40
Buffalo 37
São Paulo 37
Chicago 35
Shanghai 35
Turku 34
Orem 31
Madrid 28
Jakarta 26
Des Moines 25
Hanoi 25
London 24
Santa Clara 24
Shenyang 24
Tokyo 24
Moscow 21
Brussels 20
Washington 20
San Diego 19
Boston 18
Hebei 17
Jinan 17
Lancaster 17
Nanchang 17
Nuremberg 17
Amsterdam 16
Frankfurt am Main 16
Lappeenranta 16
Redondo Beach 16
Chennai 15
Phoenix 14
Atlanta 13
Guangzhou 13
Johannesburg 13
Montreal 13
Tianjin 13
Boardman 12
Brooklyn 12
Denver 12
Hangzhou 12
Changsha 11
Manchester 11
Zhengzhou 11
Brno 10
Fara Gera d'Adda 10
San Mateo 10
Haikou 9
Rio de Janeiro 9
Rome 9
Stockholm 9
Toronto 9
Ankara 8
Augusta 8
Bishkek 8
Hefei 8
Paris 8
Bangkok 7
Charlotte 7
Kunming 7
Mexico City 7
Mumbai 7
Salt Lake City 7
Baghdad 6
Chengdu 6
Curitiba 6
Guarulhos 6
Jiaxing 6
Lanzhou 6
Totale 6.160
Nome #
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors 346
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers 301
Claudin3 is localized outside the tight junctions in human carcinomas 290
β3 Integrin promotes long-lasting activation and polarization of vascular endothelial growth factor receptor 2 by immobilized ligand 267
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 264
Involvement of α(v)β (3) integrin in gremlin-induced angiogenesis. 238
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 226
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin. 224
A tool for the quantification of radial neo-vessels in chick chorioallantoic membrane angiogenic assays 215
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 212
d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3 207
Antiangiogenic effectiveness of the urokinase receptor- derived peptide UPARANT in a model of oxygen-induced retinopathy 206
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 204
VEGFR2 inattivo promuove la crescita tumorale modulando le caratteristiche meccaniche della matrice extra-cellulare 196
Natural Histogel-Based Bio-Scaffolds for Sustaining Angiogenesis in Beige Adipose Tissue 196
A novel pro-oncogenic mutated form of VEGFR2 modulates the activity of co-expressed wild-type receptor in melanoma 187
Enhanced SPARCL1 expression in cancer stem cells improves preclinical modeling of glioblastoma by promoting both tumor infiltration and angiogenesis 183
N-tert-butyloxycarbonyl-Phe-Leu-Phe-Leu-Phe (BOC2) inhibits the angiogenic activity of heparin-binding growth factors 163
A novel variant of VEGFR2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasis 160
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 159
Hot spot mutation in receptor tyrosine kinases elicits pro-oncogenic effects 155
VEGFR2(R1051Q) and FGFR1(D647N) correspondent mutations exhibit pro-oncogenic effects both in vitro and in vivo 151
Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy 147
Evaluation of Paracellular Permeability in VEGFR2 Mutants Patient-Derived Organoid 146
Long Pentraxin-3 Inhibits FGF8b-Dependent Angiogenesis and Growth of Steroid Hormone-Regulated Tumors. 144
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 142
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 141
cAMP-response element-binding protein (CREB) mediates the pro-angiogenic/inflammatory activity of gremlin. 141
A novel VEGFR2 mutation has oncogenic potential in BRAF wild-type melanoma 135
Role of VEGFs in metabolic disorders 134
Anti-angiogenic activity of the urokinase receptor-derived peptide UPARANT 131
Expression of activated VEGFR2 by R1051Q mutation alters the energy metabolism of Sk-Mel-31 melanoma cells by increasing glutamine dependence 129
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 128
lnvolvement of N-formyl peptide receptors in modulating the pro-angiogenic pro-inflammatory activity of human vitreous in proliferative diabetic retinopathy (POR) 128
VEGFR2 activation mediates the pro-angiogenic activity of BMP4 127
A novel VEGFR2 mutation has oncogenic potential in BRAF wild type melanoma 124
Angiogenesis-Inflammation Cross Talk in Diabetic Retinopathy: Novel Insights From the Chick Embryo Chorioallantoic Membrane/Human Vitreous Platform 124
Role of inflammation in FGF2-driven angiogenesis 123
The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features 123
Novel potential oncogenic and druggable mutations of FGFRs recur in the kinase domain across cancer types 122
In Situ DNA/Protein Interaction Assay to Visualize Transcriptional Factor Activation 118
Expansion of tumor-associated Treg cells upon disruption of a CTLA-4-dependent feedback loop 118
CHICK EMBRYO CAM/mES CELL-DERIVED TERATOMAS: A NOVEL MODEL TO STUDY TUMOR ANGIOGENESIS AND VASCULOGENESIS 116
Modeling cell motility and receptor dynamics 113
Pentraxin 3 inhibits the angiogenic potential of multiple myeloma cells 106
The expression level of VEGFR2 regulates mechanotransduction, tumor growth and metastasis of high grade serous ovarian cancer cells 103
Identification and characterization of pro-oncogenic low frequency VEGFR2 mutations 101
β-Galactosylceramidase Promotes Melanoma Growth via Modulation of Ceramide Metabolism 95
Alternative method to visualize receptor dynamics in cell membranes 94
LONG PENTRAXIN-3 INHIBITS FGF-DEPENDENT ANGIOGENESIS AND GROWTH OF STEROID HORMONE-REGULATED TUMORS 92
The BMP antagonist DRM supports angiogenesis and tumor proression 89
Acetyl-CoA carboxylase 1 controls a lipid droplet–peroxisome axis and is a vulnerability of endocrine-resistant ER+ breast cancer. 87
Protein domain-based approaches for the identification and prioritization of therapeutically actionable cancer variants 86
The Extracellular Matrix modulates mechanotransduction and metabolic alteration in EC leading to melanoma vascularization 85
The contribution of obesogenic behavior on global warming 85
The D647N mutation of FGFR1 induces ligand-independent receptor activation 84
Mutation in the Kinase Domain Alters the VEGFR2 Membrane Dynamics 82
Acetyl-CoA carboxylase 1 controls a lipid droplet–peroxisome axis and is a vulnerability of endocrine-resistant ER + breast cancer 78
Cancer-associated VEGFR2R1032Q sustains receptor activation also by promoting ligand-independent hetero-dimerization with co-expressed wild-type VEGFR2 and translocation into lipid rafts 76
Irisin regulates thermogenesis and lipolysis in 3T3-L1 adipocytes 76
Simultaneously characterization of tumoral angiogenesis and vasculogenesis in stem cell-derived teratomas 69
Production and Biochemical Characterization of Dimeric Recombinant Gremlin-1 69
The mechanics of anoikis resistance in cancer 63
The impact of adipokines on vascular networks in adipose tissue 45
Protocol for performing angiogenic and tumorigenic assays using the in ovo chick embryo chorioallantoic membrane model 40
Lipid-Protein Interplay in the Regulation of Receptor Tyrosine Kinases 38
Aberrant VEGFR2 supports tumor growth by extracellular matrix remodeling 16
The Metastatic Capacity of Melanoma Reveals Alternative Pathways of Cancer Dissemination 4
Dual targeting of EphAs and KDR axis hampers VEGF-induced angiogenesis and glioma stem cell replication 1
null 1
Totale 9.369
Categoria #
all - tutte 37.761
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.761


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021295 0 0 0 0 0 0 0 0 0 113 103 79
2021/2022471 35 79 11 18 8 27 30 26 30 61 40 106
2022/2023521 79 34 25 36 50 98 6 61 69 7 26 30
2023/2024774 41 43 84 52 44 126 46 58 113 41 25 101
2024/20251.513 47 15 23 233 134 130 138 81 152 97 263 200
2025/20263.012 300 335 217 424 366 226 521 145 233 245 0 0
Totale 9.369